Evidence map›Paper›PMID 39367444›Full record

ArticleBMC medical informatics and decision making2024

Development of brain tumor radiogenomic classification using GAN-based augmentation of MRI slices in the newly released gazi brains dataset.

M M Enes Yurtsever, Yilmaz Atay, Bilgehan Arslan, Seref Sagiroglu

Abstract read
In one paragraph

Article in BMC medical informatics and decision making, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

M M Enes YurtseverInformation Systems Engineering, Kocaeli University, Kocaeli, 41001, Türkiye.
Yilmaz AtayComputer Engineering, Engineering Faculty, Gazi University, Ankara, 06570, Türkiye. yilmazatay@gazi.edu.tr.
Bilgehan ArslanComputer Engineering, Engineering Faculty, Gazi University, Ankara, 06570, Türkiye.
Seref SagirogluComputer Engineering, Engineering Faculty, Gazi University, Ankara, 06570, Türkiye.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Significant progress has been made recently with the contribution of technological advances in studies on brain cancer. Regarding this, identifying and correctly classifying tumors is a crucial task in the field of medical imaging. The disease-related tumor classification problem, on which deep learning technologies have also become a focus, is very important in the diagnosis and treatment of the disease. The use of deep learning models has shown promising results in recent years. However, the sparsity of ground truth data in medical imaging or inconsistent data sources poses a significant challenge for training these models. The utilization of StyleGANv2-ADA is proposed in this paper for augmenting brain MRI slices to enhance the performance of deep learning models. Specifically, augmentation is applied solely to the training data to prevent any potential leakage. The StyleGanv2-ADA model is trained with the Gazi Brains 2020, BRaTS 2021, and Br35h datasets using the researchers' default settings. The effectiveness of the proposed method is demonstrated on datasets for brain tumor classification, resulting in a notable improvement in the overall accuracy of the model for brain tumor classification on all the Gazi Brains 2020, BraTS 2021, and Br35h datasets. Importantly, the utilization of StyleGANv2-ADA on the Gazi Brains 2020 Dataset represents a novel experiment in the literature. The results show that the augmentation with StyleGAN can help overcome the challenges of working with medical data and the sparsity of ground truth data. Data augmentation employing the StyleGANv2-ADA GAN model yielded the highest overall accuracy for brain tumor classification on the BraTS 2021 and Gazi Brains 2020 datasets, together with the BR35H dataset, achieving 75.18%, 99.36%, and 98.99% on the EfficientNetV2S models, respectively. This study emphasizes the potency of GANs for augmenting medical imaging datasets, particularly in brain tumor classification, showcasing a notable increase in overall accuracy through the integration of synthetic GAN data on the used datasets.

Indexed as

Brain NeoplasmsDeep LearningMagnetic Resonance ImagingHumansNeuroimagingAugmentationBrain tumorsClassificationCNNsGANsMedical imagingTransformer

Identifiers

PMID39367444
PMCPMC11450983

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.